Longitudinal lung function in childhood cancer survivors after hematopoietic stem cell transplantation
Maria Otth, Sophie Yammine, Jakob Usemann, Philipp Latzin, Luzius Mader, Ben D. Spycher, Tayfun Güngör, Katrin Scheinemann, Claudia E. Kuehni, for the Swiss Pediatric Oncology Group (SPOG), Marc Ansari, M. Beck Popovic, Jean‐Pierre Bourquin, Pierluigi Brazzola, Jeanette Greiner, Jochen Rößler, F. Schilling, Katrin Scheinemann, Nicolas von der Weid
Abstract
Longitudinal data on pulmonary function after pediatric allogeneic or autologous hematopoietic stem cell transplantation (HSCT) are rare. We examined pulmonary function and associated risk factors in 5-year childhood cancer survivors (CCSs) longitudinally. We included 74 CCSs diagnosed between 1976 and 2010, treated with HSCT, and with at least two pulmonary function tests performed during follow-up. Median follow-up was 9 years (range 6-13). We described pulmonary function as z-scores for lung volumes (forced vital capacity [FVC], residual volume [RV], total lung capacity [TLC]), flows (forced expiratory volume in 1 s [FEV1], maximal mid-expiratory flow [MMEF]), and diffusion capacity for carbon monoxide (DLCO) and assessed associations with potential risk factors using multivariable regression analysis. The median z-scores for FEV1, FVC, and TLC were below the expected throughout the follow-up period. This was not the case for RV, MMEF and DLCO. Female gender, radiotherapy to the chest, and relapse were associated with lower z-scores of FEV1, FVC, MMEF, RV or DLCO. Childhood cancer survivors after HSCT are at risk of pulmonary dysfunction. The complex and multifactorial etiology of pulmonary dysfunction emphasizes the need for longitudinal prospective studies to better characterize the course and causes of pulmonary function impairment in CCSs.